Maravai LifeSciences Holdings, Inc. (MRVI)
USD 5.58
(-3.88%)
USD 5.58
(-3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 288.94 Million | 883 Million | 799.24 Million | 284.09 Million | 143.14 Million | 123.83 Million |
| Cost of Revenue | 148.74 Million | 168.95 Million | 140.56 Million | 79.64 Million | 66.84 Million | 60.76 Million |
| Gross Profit | 140.2 Million | 714.04 Million | 658.67 Million | 204.44 Million | 76.29 Million | 63.06 Million |
| Operating Expenses | 171.85 Million | 147.62 Million | 115.28 Million | 103.54 Million | 51.98 Million | 45.69 Million |
| Selling, General and Administrative Expenses | 151.39 Million | 129.25 Million | 100.06 Million | 94.24 Million | 48.35 Million | 41.19 Million |
| Research and Development Expenses | 17.28 Million | 18.36 Million | 15.21 Million | 9.3 Million | 3.62 Million | 4.49 Million |
| Other Expenses | 3.18 Million | -358 Thousand | 279 Thousand | -7.46 Million | 118 Thousand | 87 Thousand |
| Cost and Expenses | 320.59 Million | 316.58 Million | 255.84 Million | 183.19 Million | 118.83 Million | 106.45 Million |
| Operating Income | -31.64 Million | 574.21 Million | 554.64 Million | 67.59 Million | 23.98 Million | 16.43 Million |
| Interest Expense | 45.89 Million | 20.41 Million | 30.26 Million | 30.74 Million | 29.95 Million | 27.39 Million |
| Income Tax Expense | 756.11 Million | 60.8 Million | 61.51 Million | 2.88 Million | -652 Thousand | 417 Thousand |
| Earnings before Tax | 617.73 Million | 551.47 Million | 530.76 Million | 81.69 Million | -5.85 Million | -16.49 Million |
| Net Income | -119.02 Million | 490.66 Million | 469.25 Million | 76.88 Million | -5.2 Million | -17.73 Million |
| Earnings Per Share Basic | -0.90 | 3.73 | 4.09 | 0.80 | -0.05 | -0.20 |
| Earnings Per Share Diluted | -0.90 | 1.92 | 1.82 | 0.70 | -0.05 | -0.20 |
| Weighted Average Shares Outstanding | 131.91 Million | 131.54 Million | 114.79 Million | 96.64 Million | 96.64 Million | 88.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 131.91 Million | 255.32 Million | 257.8 Million | 96.64 Million | 96.64 Million | 88.96 Million |
| Gross Margin | 0.49 | 0.81 | 0.82 | 0.72 | 0.53 | 0.51 |
| EBIT Margin | 2.47 | 0.64 | 0.68 | 0.33 | 0.34 | 0.32 |
| Profit Margin | -0.41 | 0.56 | 0.59 | 0.27 | -0.04 | -0.14 |
| EBITDA | 712.4 Million | 609.98 Million | 585.77 Million | 138.27 Million | 48.19 Million | 33.24 Million |
| Earnings Before Tax Margin | -0.11 | 0.65 | 0.69 | 0.24 | 0.17 | 0.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 73.4 Million | 64.17 Million | 288.94 Million | 74.14 Million | 66.86 Million | 68.91 Million |
| Cost of Revenue | 45.14 Million | 45.2 Million | 151.34 Million | 35.7 Million | 36.68 Million | 43.27 Million |
| Gross Profit | 28.26 Million | 18.97 Million | 137.6 Million | 38.43 Million | 30.17 Million | 25.64 Million |
| Operating Expenses | 40.07 Million | 36.22 Million | 141.79 Million | 38.22 Million | 43.21 Million | 39.57 Million |
| Selling, General and Administrative Expenses | 34.78 Million | 31.19 Million | - | 33.62 Million | 38.86 Million | 35.37 Million |
| Research and Development Expenses | 5.28 Million | 5.03 Million | - | 4.59 Million | 4.34 Million | 4.19 Million |
| Other Expenses | -2.56 Million | 106 Thousand | -1.33 Million | 49 Thousand | 66 Thousand | -1.62 Million |
| Cost and Expenses | 85.21 Million | 81.43 Million | 293.14 Million | 73.92 Million | 79.89 Million | 82.84 Million |
| Operating Income | -11.81 Million | -17.25 Million | -4.19 Million | 213 Thousand | -15.41 Million | -11.61 Million |
| Interest Expense | 11.93 Million | -10.86 Million | 45.89 Million | 15.4 Million | 11.63 Million | 7.02 Million |
| Income Tax Expense | -2.43 Million | 271 Thousand | 756.11 Million | 766.16 Million | -5.46 Million | -1.42 Million |
| Earnings before Tax | -16.92 Million | -22.4 Million | 617.73 Million | 656.18 Million | -20.56 Million | -13.36 Million |
| Net Income | -7.58 Million | -12.07 Million | -119.02 Million | -105.95 Million | -6.46 Million | -6.54 Million |
| Earnings Per Share Basic | -0.06 | -0.09 | - | -0.80 | -0.05 | -0.05 |
| Earnings Per Share Diluted | -0.06 | -0.09 | - | -0.80 | -0.05 | -0.05 |
| Weighted Average Shares Outstanding | 135.84 Million | 132.33 Million | 131.91 Million | 132.13 Million | 131.93 Million | 131.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.84 Million | 132.33 Million | 131.91 Million | 132.13 Million | 131.93 Million | 131.86 Million |
| Gross Margin | 0.39 | 0.30 | 0.48 | 0.52 | 0.45 | 0.37 |
| EBIT Margin | 0.04 | -0.05 | - | 0.18 | -0.08 | -0.13 |
| Profit Margin | -0.10 | -0.19 | -0.41 | -1.43 | -0.10 | -0.09 |
| EBITDA | 2.73 Million | -3.5 Million | - | 13.19 Million | -5.53 Million | -8.75 Million |
| Earnings Before Tax Margin | -0.16 | -0.27 | -0.01 | 0.00 | -0.23 | -0.17 |
300823
0KXA
OPCE
PCTN
300539
6069